Ascentage Pharma Group International Unsponsored ADR ( (AAPG) ) has provided an update.
On March 12, 2025, Ascentage Pharma announced it will release its full-year 2024 financial results and provide a corporate update on March 27, 2025. This announcement indicates the company’s commitment to transparency and could impact its market positioning by informing stakeholders of its financial health and recent developments.
More about Ascentage Pharma Group International Unsponsored ADR
Ascentage Pharma is a global biopharmaceutical company focused on discovering, developing, and commercializing therapies to address unmet medical needs, primarily in hematological malignancies. The company is listed on the Main Board of the Stock Exchange of Hong Kong and the Nasdaq Global Market.
YTD Price Performance: 9.32%
Average Trading Volume: 178,106
Current Market Cap: $1.65B
Find detailed analytics on AAPG stock on TipRanks’ Stock Analysis page.
Trending Articles:
Questions or Comments about the article? Write to editor@tipranks.com